Association of Pediatric Heart Transplant Coronary Vasculopathy with Abnormal Hemodynamic Measures
dc.contributor.author | Aiyagari, Ranjit | en_US |
dc.contributor.author | Nika, Melisa | en_US |
dc.contributor.author | Gurney, James G. | en_US |
dc.contributor.author | Donohue, Janet E. | en_US |
dc.contributor.author | Zamberlan, Mary C. | en_US |
dc.contributor.author | King, Karen | en_US |
dc.contributor.author | Crowley, Dennis C. | en_US |
dc.contributor.author | Gajarski, Robert J. | en_US |
dc.date.accessioned | 2015-07-01T20:56:14Z | |
dc.date.available | 2015-07-01T20:56:14Z | |
dc.date.issued | 2011-03 | en_US |
dc.identifier.citation | Aiyagari, Ranjit; Nika, Melisa; Gurney, James G.; Donohue, Janet E.; Zamberlan, Mary C.; King, Karen; Crowley, Dennis C.; Gajarski, Robert J. (2011). "Association of Pediatric Heart Transplant Coronary Vasculopathy with Abnormal Hemodynamic Measures." Congenital Heart Disease 6(2). | en_US |
dc.identifier.issn | 1747-079X | en_US |
dc.identifier.issn | 1747-0803 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/111940 | |
dc.description.abstract | Objective. Transplant coronary artery disease (TCAD) is the limiting factor to long‐term cardiac allograft survival; however, presymptomatic diagnosis remains challenging. To that concern, we evaluated the association of abnormal catheter‐derived filling pressures with TCAD in pediatric heart transplant (HTx) recipients.Design, Patients, Outcome Measures. Data from 52 presymptomatic pediatric HTx patients were analyzed. Catheter‐derived right ventricular end‐diastolic pressure (RVEDP) and pulmonary capillary wedge pressure (PCWP) were recorded. Biopsies were collected to verify the absence of rejection.Results. TCAD was diagnosed an average of 8.3 years post‐HTx in 20 (38%) patients, six of whom died and four of whom underwent retransplantation. Catheter‐derived pressure measurements showed that RVEDP was elevated in TCAD compared with non‐TCAD patients (9.5 ± 6.0 vs. 5.4 ± 4.7; P= .005), as was the PCWP (12.9 ± 5.7 vs. 9.1 ± 5.7; P= .012). Results from logistic regression analysis showed RVEDP > 10 mm Hg or PCWP > 12 mm Hg was associated with TCAD (OR = 5.2; P= .010).Conclusions. In this series, elevated ventricular filling pressures measured during routine surveillance catheterizations were associated with angiographic TCAD. Recognizing the association between elevated RVEDP/PCWP and TCAD may prompt earlier diagnosis and treatment of this potentially lethal process. | en_US |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Pediatric Transplant Coronary Vasculopathy | en_US |
dc.title | Association of Pediatric Heart Transplant Coronary Vasculopathy with Abnormal Hemodynamic Measures | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | C.S. Mott Children's Hospital, Division of Pediatric Cardiology, University of Michigan Health Center, Ann Arbor, MI, USA | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/111940/1/j.1747-0803.2010.00470.x.pdf | |
dc.identifier.doi | 10.1111/j.1747-0803.2010.00470.x | en_US |
dc.identifier.source | Congenital Heart Disease | en_US |
dc.identifier.citedreference | Kirk R, Edwards L, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric heart transplantation report—2008. J Heart Lung Transplant. 2008; 27: 970 – 977. | en_US |
dc.identifier.citedreference | Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report—2005. J Heart Lung Transplant. 2005; 24: 968 – 982. | en_US |
dc.identifier.citedreference | Pahl E, Zales VR, Fricker FJ, Addonizio LJ. Posttransplant coronary artery disease in children. A multicenter national survey. Circulation. 1994; 90: II56 – II60. | en_US |
dc.identifier.citedreference | Mulla NF, Johnston JK, Vander Dussen L, et al. Late rejection is a predictor of transplant coronary artery disease in children. J Am Coll Cardiol. 2001; 37: 243 – 250. | en_US |
dc.identifier.citedreference | Costello JM, Wax DF, Binns HJ, Backer CL, Mavroudis C, Pahl E. A comparison of intravascular ultrasound with coronary angiography for evaluation of transplant coronary disease in pediatric heart transplant recipients. J Heart Lung Transplant. 2003; 22: 44 – 49. | en_US |
dc.identifier.citedreference | Di Filippo S, Semiond B, Roriz R, Sassolas F, Raboisson MJ, Bozio A. Non‐invasive detection of coronary artery disease by dobutamine‐stress echocardiography in children after heart transplantation. J Heart Lung Transplant. 2003; 22: 876 – 882. | en_US |
dc.identifier.citedreference | Dipchand AI, Bharat W, Manlhiot C, Safi M, Lobach NE, McCrindle BW. A prospective study of dobutamine stress echocardiography for the assessment of cardiac allograft vasculopathy in pediatric heart transplant recipients. Pediatr Transplant. 2008; 12: 570 – 576. | en_US |
dc.identifier.citedreference | Schubert S, Abdul‐Khaliq H, Wellnhofer E, et al. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients. J Heart Lung Transplant. 2008; 27: 514 – 521. | en_US |
dc.identifier.citedreference | Tona F, Caforio ALP, Montisci R, et al. Coronary flow velocity pattern and coronary flow reserve by contrast‐enhanced transthoracic echocardiography predict long‐term outcome in heart transplantation. Circulation. 2006; 114: I49 – I55. | en_US |
dc.identifier.citedreference | Maiers J, Hurwitz R. Identification of coronary artery disease in the pediatric cardiac transplant patient. Pediatr Cardiol. 2008; 29: 19 – 23. | en_US |
dc.identifier.citedreference | Law Y, Boyle G, Miller S, et al. Restrictive hemodynamics are present at the time of diagnosis of allograft coronary artery disease in children. Pediatr Transplant. 2006; 10: 948 – 952. | en_US |
dc.identifier.citedreference | Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988; 12: 334 – 340. | en_US |
dc.identifier.citedreference | Leman NR, Levi DS, Alejos JC, Wetzel GT. Predictors of graft longevity in pediatric heart transplantation. Pediatr Cardiol. 2005; 26: 762 – 767. | en_US |
dc.identifier.citedreference | Raichlin E, Bae J‐H, Khalpey Z, et al. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation. 2007; 116: 2726 – 2733. | en_US |
dc.identifier.citedreference | Quinones M. Evaluation of intracardiac filling pressures. In: Klein AL, Garcia MJ, eds. Diastology: Clinical Approach to Diastolic Heart Failure. Philadelphia, Pa: Saunders/Elsevier; 2008: 181 – 192. | en_US |
dc.identifier.citedreference | Ventura HO, Mehra MR, Smart FW, Stapleton DD. Cardiac allograft vasculopathy: current concepts. Am Heart J. 1995; 129: 791 – 799. | en_US |
dc.identifier.citedreference | Hathout E, Beeson WL, Kuhn M, et al. Cardiac allograft vasculopathy in pediatric heart transplant recipients. Transpl Int. 2006; 19: 184 – 189. | en_US |
dc.identifier.citedreference | Mancini D, Pinney S, Burkhoff D, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 2003; 108: 48 – 53. | en_US |
dc.identifier.citedreference | Zakliczynski M, Swierad M, Nozynski J, Maruszewski M, Zembala M. Survival benefit in heart transplant recipients who have coronary artery disease confirmed using angiography and are receiving sirolimus. Transplant Proc. 2009; 41: 285 – 288. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.